In this commentary, we respond to the conclusions of recent publications by (7, 8) * The authors used urinary arsenic concentrations from grab samples as the basis for evaluating methylating capacity. However, the proportion of inorganic arsenic excreted in the urine varies substantially over time; thus, an individual grab sample is not representative of the degree of methylation that is occurring. Studies by Buchet et al. (6) show that after ingestion of inorganic arsenic, the proportion of arsenic in the urine that is inorganic arsenic is high soon after exposure (0-12 hr), but much lower later on (>12 hr). The appropriate measurement with which to examine metabolism and elimination of arsenic is the total mass of inorganic arsenic and its metabolites eliminated over a 24-to 48-hr time period; using mass per time rather than concentration would control not only for variability in the proportions of the metabolites over the course of a day, but also for variability in urine volume. A recent 7-day diet study in Japan found that the intake and excretion of total arsenic were balanced when averaged over a week but not over 1 day (9). Smith et al. Currently, the CSF for ingested arsenic is based on the incidence of nonmelanoma skin cancers associated with exposure to high levels of arsenic in drinking water in Taiwan; however, Smith et al. have suggested that arsenic could be an important risk factor not only for skin cancer, but also for several internal cancers including lung, liver, bladder, and kidney. Smith et al. used the data from another epidemiological study in Taiwan (10) to examine
In this commentary, we respond to the conclusions of recent publications by Hopenhayn-Rich et al. (1) and Smith et al. (2) regarding issues of arsenic risk assessment. Although Hopenhayn-Rich et al. was not published in Environmental Health Perspectives, we believe that it is important to examine these studies and their relevance to risk assessment together.
In 1988 the Risk Assessment Forum of the U.S. Environmental Protection Agency developed a cancer slope factor (CSF; the U.S. EPA estimate of carcinogenic potency) for arsenic based on an ecological epidemiology study relating skin cancer to arsenic ingestion in Taiwan. Several important questions have been raised about this CSF. One issue with this CSF is that it assumes a linear dose-response relationship for cancer, and thus it does not reflect increasing evidence indicating either a threshold or a sublinear dose-response relationship for low doses of arsenic (3, 4) .
[Saturation of the methylation detoxification pathway has been proposed as one explanation for the sublinear doseresponse relationship for arsenic (5) .] Another issue is whether ingestion of arsenic is associated with cancers other than skin cancer.
EPA is currently under a judicial mandate to evaluate whether the existing maximum contaiminant level (MCL) should be revised (the current MCL is 50 pg/l). In evaluating the existing MCL and the possible need for a revised MCL, EPA -The average arsenic exposures in almost all of the studies analyzed were too low to observe methylation saturation. Evidence from the study by Buchet et al. (6) suggests that methylation would be completely saturated at exposures greater than 500 pg/day, with corresponding total urinary arsenic output of approximately 290 pg/day at steady state. If average daily urine output is 1.5 1/day (1) , this is equivalent to an average urinary arsenic concentration of about 190 pg/l. Among the 28 populations analyzed by Hopenhayn-Rich, only two populations (7, 8) had average urinary arsenic concentrations at or above 190 pg/l (238 and 245 pg/I, respectively); a regression analysis on the individual data within the Yamauchi et al. (7) population was borderline significant at p = 0.10 [individual data were not available for the Farmer and Johnson population (8) ].
* The authors used urinary arsenic concentrations from grab samples as the basis for evaluating methylating capacity. However, the proportion of inorganic arsenic excreted in the urine varies substantially over time; thus, an individual grab sample is not representative of the degree of methylation that is occurring. Studies by Buchet et al. (6) show that after ingestion of inorganic arsenic, the proportion of arsenic in the urine that is inorganic arsenic is high soon after exposure (0-12 hr), but much lower later on (>12 hr). The appropriate measurement with which to examine metabolism and elimination of arsenic is the total mass of inorganic arsenic and its metabolites eliminated over a 24-to 48-hr time period; using mass per time rather than concentration would control not only for variability in the proportions of the metabolites over the course of a day, but also for variability in urine volume. A recent 7-day diet study in Japan found that the intake and excretion of total arsenic were balanced when averaged over a week but not over 1 day (9) . Smith et al. Currently, the CSF for ingested arsenic is based on the incidence of nonmelanoma skin cancers associated with exposure to high levels of arsenic in drinking water in Taiwan; however, Smith et al. have suggested that arsenic could be an important risk factor not only for skin cancer, but also for several internal cancers including lung, liver, bladder, and kidney. Smith et al. used the data from another epidemiological study in Taiwan (10) (12, 13) and assuming a water consumption rate of 4.5 I/day and 18 pg/day As in food, using the most current EPA arsenic intake estimates for Taiwan (14) ]. As 
